APAC's Premier CGT Congress - Advancing Cell & Gene Therapies from Discovery to Commercialization

23 - 24 March 2027 Sands Expo & Convention Centre, Singapore
Part of Biopharma APAC Confex 2027
Register Now
Co-located Events
OPWA 2027 - White Logo Visit Brochure
BMA 2027 (White) Visit Brochure
BSCA 2027 (White) Visit Brochure
ADC 2027 (White) Visit Brochure
CTFA 2027 (White) Visit Brochure

About the Event

As the region emerges as a global leader in regenerative medicine, Cell & Gene Therapy World Asia 2027 (#CGTAsia2027) returns as Asia’s most anticipated CGT knowledge-sharing conference for the 11th year! Designed to connect and empower stakeholders from the cell and gene therapy ecosystem, the event provides an unparalleled platform to explore the latest advancements in cell therapies, gene therapies, and CAR-T technologies.

‍Event Highlights:

  • Hear from 50+ leading industry experts across Singapore, China, Japan, South Korea, Taiwan, and Australia as they share the latest advancements and future directions in cell and gene therapy, spanning CAR-T, TCR-T, gene editing, viral vectors, and next-generation CGT manufacturing platforms.

  • Engage with 500+ senior-level decision-makers across biopharma, big pharma, CDMOs, academia, and technology providers to gain forward-looking insights into CGT development, clinical translation, manufacturing scale-up, and commercialization strategies in Asia. 

  • Participate in a dedicated Poster Presentation Session showcasing cutting-edge CGT research, translational science, vector engineering, and early-stage innovations from leading academic institutes, biotech startups, and clinical research teams across Asia.

Why Asia?

The region continues to be a global leader in gene and cell therapy with a compound annual growth rate surpassing 40%. Factors driving this growth include:

  • Government & Regulatory Support

  • Rising Prevalence of Chronic Diseases: Growing demand for advanced therapeutics.

  • Innovation & Clinical Trials: Asia's appeal as a research and clinical trial hub.

  • Strategic Collaborations: Partnerships between biopharma, CDMOs, and academic institutions.

With Asia emerging as the next frontier for cell and gene therapy innovation, #CGTAsia2027 is the premier event to connect, collaborate, and redefine the future of regenerative medicine. Be apart of this transformative journey.

What we'll cover

Key Themes

Next-Generation Cell & Gene Therapy Innovation
Exploring CAR-T, gene editing, NK cell therapies, stem cell platforms, and emerging advanced therapeutic modalities.
Clinical Translation & Development Pathways
Accelerating the journey from discovery and preclinical research to first-in-human studies and clinical success.
CGT Manufacturing, Scale-Up & CMC Readiness
Addressing process development, technology transfer, manufacturing scalability, quality control, and commercial readiness.
Digitalisation, Automation & Operational Excellence
Leveraging smart manufacturing, analytics, automation, and advanced technologies to improve efficiency and reliability.
Regulatory, Commercialisation & Patient Access Strategies
Navigating regulatory pathways, market access, supply chain challenges, and strategies to deliver advanced therapies to patients.
BY THE NUMBERS

Our Impact in Asia's Biopharma

500+
Attendees

Join over 500 professionals at the 11th Annual Cell & Gene Therapy World Asia! Connect with key industry players, expand your network, and engage in high-level discussions shaping the future of biologics.

150+
Companies

Meet 150 leading companies driving innovation in the biologics sector. Whether you're seeking new partners or exploring the latest breakthroughs, this is the ideal platform to discover what’s next in the industry.

50+
Speakers

Gain exclusive insights from 50 expert speakers shaping the future of biologics. Learn from the best in the field as they share cutting-edge knowledge, practical solutions, and emerging trends you won’t want to miss.

Sponsors & Media Partners

Special thanks to our event partners, without whom we would not be able to provide this networking, learning, and collaborating platform.

Media & Publicity
Life Sciences Review
BioPharma Asia Logo
Cell & Gene

Agenda At A Glance

CONFERENCE DAY 1 | 23rd March 2027
CONFERENCE DAY 2 | 24th March 2027
Innovation & Translation Manufacturing & Commercialization
Next-Generation Cell & Gene Therapies
CAR-T, Gene Editing & Emerging Modalities
Advanced Cell Therapies
Beyond Traditional CAR-T
Morning Tea, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
From Discovery to Clinical Translation
Accelerating CGT Development
Manufacturing Excellence
Scale-Up, Tech Transfer & CMC Readiness 
Lunch, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Gene & Cell Therapy Platforms
Vector Engineering, Delivery & Analytics 
Supply Chain & Operational Excellence for CGTs
Afternoon Tea, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Smart Manufacturing & Process Development for CGTs
Regulatory Pathways, Market Access & Commercialization
End of Conference Day 1 End of Conference
Asia Pacific Cell & Gene Therapy Excellence Awards 2027
CONFERENCE DAY 1 | 23rd March 2027
Innovation & Translation
Next-Generation Cell & Gene Therapies
CAR-T, Gene Editing & Emerging Modalities
Morning Tea, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
From Discovery to Clinical Translation
Accelerating CGT Development
Lunch, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Gene & Cell Therapy Platforms
Vector Engineering, Delivery & Analytics 
Afternoon Tea, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Smart Manufacturing & Process Development for CGTs
End of Conference Day 1
Asia Pacific Cell & Gene Therapy Excellence Awards 2027
CONFERENCE DAY 2 | 24th March 2027
Manufacturing & Commercialization
Advanced Cell Therapies
Beyond Traditional CAR-T
Morning Tea, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Manufacturing Excellence
Scale-Up, Tech Transfer & CMC Readiness 
Lunch, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Supply Chain & Operational Excellence for CGTs
Afternoon Tea, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Regulatory Pathways, Market Access & Commercialization
End of Conference
CONFERENCE AGENDA

Day 1

Tuesday, 23 March 2027

OPENING THEME
Innovation & Translation
8:50
IMAPAC Opening Remarks
8:55
Chairman Welcome Remarks
Next-Generation Cell & Gene Therapies: CAR-T, Gene Editing & Emerging Modalities
9:00
Panel Discussion: Next-Generation Cell & Gene Therapies: Advancing CAR-T, Gene Editing and Emerging Therapeutic Modalities in Asia
  • How are emerging technologies such as CAR-T, gene editing, and engineered immune cell therapies shaping the next generation of CGT development in Asia?
  • What are the key scientific, manufacturing, and clinical challenges that need to be addressed to accelerate CGT translation from research to patient access?
  • How can Asia strengthen its CGT ecosystem through collaboration across biotech companies, research institutions, hospitals, and manufacturing partners?
9:45
Enabling Scalable Cell & Gene Therapy Development Through Advanced Manufacturing Solutions
  • Optimising workflows for scalable CGT production
  • Improving process control, automation, and manufacturing efficiency
  • Supporting GMP readiness from development to commercialisation
Reserved for Solution Provider
10:00
Real-World Challenges in Advancing Cell & Gene Therapies: From Clinical Development to Commercial Success
  • Lessons learned from developing and translating CGT platforms
  • Overcoming manufacturing, regulatory, and operational barriers
  • Preparing next-generation therapies for broader patient access
10:25
Morning Break, Exhibition Viewing & 1-1 Networking
From Discovery to Clinical Translation: Accelerating CGT Development
11:10
Translating Innovative Cell Therapy Platforms from Discovery to Clinical Development
  • Advancing novel CGT candidates from preclinical research into human trials
  • Addressing scientific and operational barriers during development
  • Lessons learned from early-stage clinical translation
11:35
Accelerating CGT Development Through Integrated Technologies and Innovative Workflow Solutions
  • Enabling faster transition from discovery to clinical-stage development
  • Improving efficiency through advanced analytics and automation
  • Supporting reproducible and scalable CGT workflows
Reserved for Solution Provider
11:50
Building Clinical-Ready Cell & Gene Therapies: Bridging Research, Manufacturing and Patient Delivery
  • Aligning research, CMC, and clinical strategies for successful development
  • Managing technology transfer and manufacturing readiness
  • Preparing CGT programs for regulatory milestones
12:15
Accelerating CGT Innovation in Asia: Creating Pathways from Discovery to Patient Access
  • Expanding CGT development across Asia Pacific markets
  • Building collaborations between biotech, hospitals, and research institutions
  • Overcoming regulatory and commercialisation challenges
12:40
Lunch, Exhibition Viewing, Poster Presentations & 1-1 Networking
Gene & Cell Therapy Platforms: Vector Engineering, Delivery & Analytics
2:00
Optimising Viral Vector Platforms for Next-Generation Gene Therapies
  • Advances in viral vector design and manufacturing strategies
  • Improving potency, safety, and scalability
  • Overcoming challenges in clinical translation
2:25
Enabling Next-Generation CGT Development Through Advanced Vector, Delivery and Analytical Technologies
  • Improving vector design, optimisation, and production efficiency
  • Supporting accurate characterisation and quality assessment of CGT products
  • Accelerating development timelines through innovative technology platforms
Reserved for Solution Provider
2:40
Beyond Delivery Challenges: Building Effective and Scalable Gene Therapy Platforms
  • Emerging delivery technologies for gene and cell therapies
  • Enhancing therapeutic targeting and patient outcomes
  • Lessons from clinical development programs
3:05
Harnessing Advanced Analytics to Improve CGT Development and Manufacturing Quality
  • Role of analytics in product characterisation and release testing
  • Using data-driven approaches to improve process control
  • Supporting regulatory readiness for CGT products
3:30
Afternoon Break, Exhibition Viewing & 1-1 Networking
Smart Manufacturing & Process Development for CGTs
4:10
Scaling Cell & Gene Therapy Manufacturing: From Development Processes to Commercial Production
  • Challenges in scaling CGT manufacturing operations
  • Optimising processes for consistency and quality
  • Preparing manufacturing platforms for commercial demand
4:35
Transforming CGT Manufacturing Through Automation, Digitalisation and Process Innovation
  • Enabling smarter and more efficient CGT manufacturing workflows
  • Improving process monitoring, automation, and data integration
  • Supporting GMP readiness and scalable production
Reserved for Solution Provider
4:50
Building the Future of CGT Manufacturing: Digitalisation, Automation and Operational Excellence
  • Implementing smart manufacturing strategies for advanced therapies
  • Leveraging digital tools for process optimisation
  • Improving manufacturing agility and efficiency
5:15
End of Conference Day 1
6:00
Asia Pacific Cell & Gene Therapy Excellence Awards 2027
CONFERENCE AGENDA

Day 2

Wednesday, 24 March 2027

OPENING THEME
Manufacturing & Commercialization
8:50
IMAPAC Opening Remarks
8:55
Chairman Welcome Remarks
Advanced Cell Therapies: Beyond Traditional CAR-T
9:00
Beyond CAR-T: Advancing Next-Generation Immune Cell Therapies for Improved Patient Outcomes
  • Evolution of CAR-NK, TCR-T, and engineered immune cell platforms
  • Addressing limitations of current CAR-T approaches
  • Translating novel cell therapies into clinical applications
9:25
Enabling Next-Generation Cell Therapies Through Advanced Manufacturing and Cell Engineering Technologies
  • Supporting development of innovative cell therapy platforms beyond CAR-T
  • Improving cell engineering, automation, and manufacturing workflows
  • Enabling scalable and reproducible production for clinical applications
Reserved for Solution Provider
9:40
The Future of Cell Therapy: Harnessing iPSC, Gene Editing and Universal Cell Platforms
  • Development of off-the-shelf cell therapy approaches
  • Improving scalability and manufacturing efficiency
  • Expanding access to advanced therapies
10:05
Engineering Smarter Cell Therapies: Innovation Pathways from Research to Clinical Development
  • Advances in cell engineering technologies
  • Improving therapeutic potency and safety profiles
  • Overcoming challenges in clinical translation
10:30
Morning Break, Exhibition Viewing & 1-1 Networking
Manufacturing Excellence: Scale-Up, Tech Transfer & CMC Readiness
11:10
From Clinical Manufacturing to Commercial Scale: Building Robust CGT Production Platforms
  • Challenges in scaling cell and gene therapy manufacturing
  • Developing reliable GMP manufacturing processes
  • Preparing facilities and operations for commercial supply
11:35
Enabling Scalable CGT Manufacturing Through Advanced Process Technologies and CMC Solutions
  • Supporting efficient scale-up from development to GMP production
  • Improving process control, automation, and manufacturing consistency
  • Accelerating CMC readiness for regulatory approval
Reserved for Solution Provider
11:50
Successful Tech Transfer in CGT: Bridging Development, Manufacturing and Regulatory Requirements
  • Managing technology transfer between sites and partners
  • Maintaining product quality during process changes
  • Aligning manufacturing strategies with regulatory expectations
12:15
CMC Readiness for Next-Generation Therapies: Overcoming Manufacturing and Regulatory Challenges
  • Building CMC strategies early in CGT development
  • Addressing analytical, quality, and process challenges
  • Supporting faster progression toward market approval
12:40
Lunch, Exhibition Viewing, Poster Presentations & 1-1 Networking
Supply Chain & Operational Excellence for CGTs
2:00
From Vein-to-Vein: Optimising Cell Therapy Supply Chains for Clinical and Commercial Success
  • Managing patient-specific therapy logistics
  • Improving coordination between collection, manufacturing, and delivery
  • Reducing operational risks across the CGT journey
2:25
Building Resilient CGT Supply Chains Through Advanced Logistics, Traceability and Digital Solutions
  • Improving end-to-end visibility across CGT supply networks
  • Ensuring product integrity through temperature-controlled logistics
  • Supporting scalable operations for personalised therapies
Reserved for Solution Provider
2:40
Scaling CGT Operations: Building Infrastructure for Global Cell Therapy Delivery
  • Developing scalable operational models for growing CGT demand
  • Managing manufacturing capacity and supply continuity
  • Preparing for commercial deployment across regions
3:05
Digital Transformation in CGT Supply Chains: Enhancing Visibility, Compliance and Efficiency
  • Using digital platforms for tracking and traceability
  • Improving data integration across CGT workflows
  • Supporting regulatory compliance and operational excellence
3:30
Afternoon Break, Exhibition Viewing & 1-1 Networking
Regulatory Pathways, Market Access & Commercialization
4:10
From Approval to Adoption: Building Successful Commercial Strategies for Cell & Gene Therapies
  • Navigating regulatory pathways for advanced therapies
  • Developing market access strategies for innovative treatments
  • Preparing CGTs for commercial launch and patient availability
4:35
Commercialising Cell & Gene Therapies: Overcoming Regulatory and Healthcare System Challenges
  • Managing regulatory requirements across global markets
  • Addressing reimbursement and healthcare adoption barriers
  • Creating sustainable commercial models for CGT delivery
5:00
The Future of CGT in Asia: Building Regulatory Alignment and Expanding Patient Access
  • Regulatory evolution across Asia Pacific markets
  • Opportunities for regional CGT collaboration
  • Accelerating access to advanced therapies for patients
5:25
Chairman Closing Remarks
5:30
End of Conference
Register Now
By Profile
Cell Therapy Companies & Biopharma (Asia)
45%
Cell Therapy Companies & Biopharma (International)
15%
Big Pharma
10%
CRO & CMO/CDMO
12%
Government & Academic Research Institutes
7%
Technology & Service Providers
8%
Others
3%
By Job Title
CEOs, CSOs, CTOs & President
20%
VPs, Directors, Head of Cell & Gene Therapy Development & Regenerative Medicine
30%
Manager & Head of Research & Development
20%
Research Scientist & Professor
15%
Marketing, Sales and Business Development
10%
Others
5%
By Geography
World Map
10%
Europe & USA
15%
China & Taiwan
20%
South Korea
10%
Japan
15%
Hong Kong, India & Philippines
30%
Indonesia, Malaysia, Singapore & Thailand
10%
Europe & USA
15%
China & Taiwan
20%
South Korea
10%
Japan
15%
Hong Kong, India & Philippines
30%
Indonesia, Malaysia, Singapore & Thailand

Who Should Sponsor?

Bioprocessing Equipment Vendors
Clinical Research Organization (CRO's)
Diagnostics & Analytical Tools
Lab Equipment/Sterilization, Purification/Equipments (Columns, Centrifuges, Homogenizers, Chromatography Columns)
Logistic Service Providers
Engineering/Facility/Design
International CMOS's
Cell Lines
Cold Chain
Cell Culture Media/Lab Equipments
Others (Drug Distributors, Disinfection, Refrigerator, ETC)
SPONSORSHIP BENEFITS

Why Sponsor This Event?

Thought Leadership

Present Your Expertise to the Biopharma Industry's Key Stakeholders through a Variety of Available Speaking Packages.

Host a Panel Discussion

Moderate a panel discussion including one representative from your company with 3 representatives from the end user side to share views on a current industry topic

Duration: 45 minutes

Showcase Your Solutions to Educate the Market

Join in for dedicated CMO & CRO Showcases

Branding

Emphasize on your Message by Marketing and Promoting Alongside the Event

Networking & Lead Generation

Gain Exclusive Access to Contacts of High Profile Attendees through Intimate Networking Opportunities

Our Past Partners

Sartorius Logo
Becton_Dickinson_logo.svg
IDBS_Logo
WuXi Biologics
Merck
solventum-logo-horz-clr-pos-rgb
Pfanstiehl-hd
DYE logo blue 1
Aurigene
lonza
cytiva-logo-vector
avantor-inc-logo-vector
Charles_River_Laboratories_Logo.svg
Truking logo 1
cellist-1
watson-marlow (1)
Aber
Single Use Support
PharmNXT Logo_COLOUR_transparent 2K
Tosoh Bioscience
Emerson_Electric_Company
Dr Paul Lohman
avantor-inc-logo-vector
Genscript GS_Logo_Primary_RGB
Acro Biosystems
Shimadzu 1
Tofflon
Jiuzhou
IKA_Logo
Gerresheimer 2
Imalife
Lisure Science
Ellab_Logo_tagline_CYAN 2_page-0001
airdynamics
unither-pharma
ATUM_RGB_Black 1
Sanisure
SHENTEK logo
Duoning-Logo-EN-small-1
Evonik
Biomed Logo (Dark Blue & Light Blue) (1) (1)
novo-nordisk
SGS_Logo.svg
Sphere Bio-use this Dark Green WSTB Primary@300x-8 1
Biohaus Media (Media Partner) Logo
BioPharma Asia Logo
Agilent-Logo-Site
Refeyn-01
and many more...
PARTNER WITH US

Sponsorship Packages

Tailored sponsorship opportunities designed to maximize your brand visibility and lead generation.

Platinum Sponsor

Speaking & thought leadership

  • 1 Conference presentation: 20 min (+ 5 min live Q&A). In the main conference sessions.
  • 1 End-user client case study: 20 min (+ 5 min live Q&A). Complimentary, in the main conference sessions.
  • 1 Pre-conference workshop: Half day (catered for 30 pax). Room hire and one refreshment included. Limited to 1 - 2 sponsors.
  • 1 Conference chairmanship: Day 2. Optional and subject to availability.
  • 1 Pre-event speaker interview. Shared with the Cell & Gene Therapy community and on social media.

Exhibition

  • 1 Exhibition space: 12 sqm (6 × 2 m table-top, upgrade to 18 sqm). In the Exhibition Hall. All upgrades are complimentary.

Passes & networking

  • 1 Speaker pass. Premium conference sessions and the Exhibition Hall.
  • 7 Conference passes. Premium conference sessions and the Exhibition Hall.
  • 2 Exhibitor passes. To staff the booth.
  • 5 1:1 meeting assistance. Help setting up meetings on site with targeted companies.

Branding & reach

  • 1 Logo placement: Priority. Official brochure front page (sent to 20,000+ targeted senior executives), event web page with a two-way link, every event ad in media partners' publications and IMAPAC's marketing including social media, and the backdrop, on-site signage and event banners.
  • 1 Corporate profile online: 200 words. Maximum length, on the official event web page.
  • 1 Brochure distribution. At the registration desk or conference table.
  • 1 Corporate gift distribution. Optional.
  • 1 In-depth post-event report. Exclusive to sponsors.
Gold Sponsor

Speaking & thought leadership

  • 1 Conference presentation: 20 min (+ 5 min live Q&A). In the main conference sessions.
  • 1 Panel or roundtable moderator. Complimentary.
  • 1 Pre-event speaker interview. Shared with the Cell & Gene Therapy community and on social media.

Exhibition

  • 1 Exhibition space: 9 sqm (4.5 × 2 m table-top, upgrade to 12 sqm). In the Exhibition Hall. All upgrades are complimentary.

Passes & networking

  • 1 Speaker pass. Premium conference sessions and the Exhibition Hall.
  • 6 Conference passes. Premium conference sessions and the Exhibition Hall.
  • 2 Exhibitor passes. To staff the booth.
  • 5 1:1 meeting assistance. Help setting up meetings on site with targeted companies.

Branding & reach

  • 1 Logo placement: Priority. Official brochure front page (sent to 20,000+ targeted senior executives), event web page with a two-way link, every event ad in media partners' publications and IMAPAC's marketing including social media, and the backdrop, on-site signage and event banners.
  • 1 Corporate profile online: 150 words. Maximum length, on the official event web page.
  • 1 Brochure distribution. At the registration desk or conference table.
  • 1 Corporate gift distribution. Optional.
  • 1 In-depth post-event report. Exclusive to sponsors.
Silver Sponsor (Enhanced)

Speaking & thought leadership

  • 1 Conference presentation: 25 min (with live Q&A). In the main conference sessions.

Exhibition

  • 1 Exhibition space: 6 sqm (3 × 2 m table-top, upgrade to 9 sqm booth). In the Exhibition Hall. All upgrades are complimentary.

Passes & networking

  • 1 Speaker pass. Premium conference sessions and the Exhibition Hall.
  • 4 Conference passes. Premium conference sessions and the Exhibition Hall.
  • 2 Exhibitor passes. To staff the booth.

Branding & reach

  • 1 Logo placement: Standard. Official brochure front page (sent to 20,000+ targeted senior executives), event web page with a two-way link, every event ad in media partners' publications and IMAPAC's marketing including social media, and the backdrop, on-site signage and event banners. Credited as Silver Sponsor.
  • 1 Corporate profile online: 100 words. Maximum length, on the official event web page.
  • 1 In-depth post-event report. Exclusive to sponsors.
Silver Sponsor

Speaking & thought leadership

  • 1 Conference presentation: 15 min (with live Q&A). In the main conference sessions.

Exhibition

  • 1 Exhibition space: 6 sqm (3 × 2 m table-top). In the Exhibition Hall. All upgrades are complimentary.

Passes & networking

  • 1 Speaker pass. Premium conference sessions and the Exhibition Hall.
  • 3 Conference passes. Premium conference sessions and the Exhibition Hall.
  • 2 Exhibitor passes. To staff the booth.

Branding & reach

  • 1 Logo placement: Standard. Official brochure front page (sent to 20,000+ targeted senior executives), event web page with a two-way link, every event ad in media partners' publications and IMAPAC's marketing including social media, and the backdrop, on-site signage and event banners.
  • 1 Corporate profile online: 100 words. Maximum length, on the official event web page.
  • 1 In-depth post-event report. Exclusive to sponsors.
Bronze Sponsor

Speaking & thought leadership

  • 1 Conference presentation: 15 min (with live Q&A). In the main conference sessions.

Exhibition

  • 1 Exhibition space: 1 sqm (upgrade to 6 sqm for first-time clients). In the Exhibition Hall. All upgrades are complimentary. Space for a banner display and/or a small networking table. The upgrade, to a 3 × 2 m table-top, is a one-time offer.

Passes & networking

  • 1 Speaker pass. Premium conference sessions and the Exhibition Hall.
  • 1 Conference passes. Premium conference sessions and the Exhibition Hall.

Branding & reach

  • 1 Logo placement: Standard. Official brochure front page (sent to 20,000+ targeted senior executives), event web page with a two-way link, every event ad in media partners' publications and IMAPAC's marketing including social media, and the backdrop, on-site signage and event banners.
  • 1 Corporate profile online: 100 words. Maximum length, on the official event web page.
  • 1 In-depth post-event report. Exclusive to sponsors.
Exhibitor

Exhibition

  • 1 Exhibition space: 6 sqm (3 × 2 m table-top). In the Exhibition Hall. All upgrades are complimentary.

Passes & networking

  • 2 Conference passes. Premium conference sessions and the Exhibition Hall.
  • 2 Exhibitor passes. To staff the booth.

Branding & reach

  • 1 Logo placement: Standard. Official brochure front page (sent to 20,000+ targeted senior executives), event web page with a two-way link, every event ad in media partners' publications and IMAPAC's marketing including social media, and the backdrop, on-site signage and event banners.
  • 1 Promotional video: 1 - 2 min. Played in the ad slots across both event days.
  • 1 Corporate profile online: 100 words. Maximum length, on the official event web page.
  • 1 In-depth post-event report. Exclusive to sponsors.

Be a Part of This Event!

Don't miss out on unique networking, speaking and sponsorship opportunities.

Register Here!
Portfolio Specialist
Caterin Sanggita
+65 6983 6137 | +62 811654788
Business Development Manager
Ana Laxamana
+65 6983 6132
Business Development Manager
Nathan Grace Niño
+65 6983 6134 | +44 161 552 8521